Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad A Rafi

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Drug Discovery Today|March 25, 2020
Epitope-based vaccine design: a comprehensive overview of bioinformatics approachesSepideh Parvizpour, Mohammad M Pourseif, Jafar Razmara, et al.
Molecular and Cellular Neurosciences|September 20, 2005
Insulin-like growth factor-1 provides protection against psychosine-induced apoptosis in cultured mouse oligodendrocyte progenitor cells using primarily the PI3K/Akt pathwayMariam Zaka, Mohammad A Rafi, Han Zhi Rao, et al.
Molecular Genetics and Metabolism|June 18, 2003
Disease-causing mutations in cis with the common arylsulfatase A pseudodeficiency allele compound the difficulties in accurately identifying patients and carriers of metachromatic leukodystrophyMohammad A Rafi, Stephanie Coppola, Shu Ling Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2012
Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe diseaseMohammad A Rafi, Han Zhi Rao, Paola Luzi, et al.
Expert Opinion on Biological Therapy|March 3, 2021
Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidosesAzam Safary, Hakimeh Moghaddas-Sani, Mostafa Akbarzadeh-Khiavi, et al.
Neurochemical Research|May 14, 2004
Generation of transgenic mice expressing insulin-like growth factor-1 under the control of the myelin basic protein promoter: increased myelination and potential for studies on the effects of increased IGF-1 on experimentally and genetically induced demyelinationPaola Luzi, Mariam Zaka, Han Zhi Rao, et al.
Molecular Genetics and Metabolism|February 17, 2009
Significant correction of pathology in brains of twitcher mice following injection of genetically modified mouse neural progenitor cellsMichelina Strazza, Alice Luddi, Marica Carbone, et al.
Neuroscience|November 5, 2019
Mathematical Models to Shed Light on Amyloid-Beta and Tau Protein Dependent Pathologies in Alzheimer's DiseaseArmin Vosoughi, Saeed Sadigh-Eteghad, Mohammad Ghorbani, et al.
Brain Research|September 15, 2009
Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophyPaola Luzi, Ronnie M Abraham, Mohammad A Rafi, et al.
Molecular Genetics and Metabolism|December 24, 2014
Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical featuresMohammad A Rafi, Han Zhi Rao, Paola Luzi, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Drug Discovery Today|March 25, 2020
Epitope-based vaccine design: a comprehensive overview of bioinformatics approachesSepideh Parvizpour, Mohammad M Pourseif, Jafar Razmara, et al.
Molecular and Cellular Neurosciences|September 20, 2005
Insulin-like growth factor-1 provides protection against psychosine-induced apoptosis in cultured mouse oligodendrocyte progenitor cells using primarily the PI3K/Akt pathwayMariam Zaka, Mohammad A Rafi, Han Zhi Rao, et al.
Molecular Genetics and Metabolism|June 18, 2003
Disease-causing mutations in cis with the common arylsulfatase A pseudodeficiency allele compound the difficulties in accurately identifying patients and carriers of metachromatic leukodystrophyMohammad A Rafi, Stephanie Coppola, Shu Ling Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2012
Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe diseaseMohammad A Rafi, Han Zhi Rao, Paola Luzi, et al.
Expert Opinion on Biological Therapy|March 3, 2021
Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidosesAzam Safary, Hakimeh Moghaddas-Sani, Mostafa Akbarzadeh-Khiavi, et al.
Neurochemical Research|May 14, 2004
Generation of transgenic mice expressing insulin-like growth factor-1 under the control of the myelin basic protein promoter: increased myelination and potential for studies on the effects of increased IGF-1 on experimentally and genetically induced demyelinationPaola Luzi, Mariam Zaka, Han Zhi Rao, et al.
Molecular Genetics and Metabolism|February 17, 2009
Significant correction of pathology in brains of twitcher mice following injection of genetically modified mouse neural progenitor cellsMichelina Strazza, Alice Luddi, Marica Carbone, et al.
Neuroscience|November 5, 2019
Mathematical Models to Shed Light on Amyloid-Beta and Tau Protein Dependent Pathologies in Alzheimer's DiseaseArmin Vosoughi, Saeed Sadigh-Eteghad, Mohammad Ghorbani, et al.
Brain Research|September 15, 2009
Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophyPaola Luzi, Ronnie M Abraham, Mohammad A Rafi, et al.
Molecular Genetics and Metabolism|December 24, 2014
Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical featuresMohammad A Rafi, Han Zhi Rao, Paola Luzi, et al.
Pageof 4